DPIIT recognised startup Government of India
Startup India
Cemil Biosciences Private Limited - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.88 Cr
▲ 28% YoY
Net loss · FY 2025
₹64.21 Lakh
Net margin -34.2%
EBITDA · FY 2025
-₹14.79 Lakh
EBITDA margin -7.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1.2 Lakh
Issued & subscribed
Open charges
₹70 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Cemil Biosciences Private Limited
Data last updated:
Cemil Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 15 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2019PTC120414. Its GSTIN is 29AAHCC9649M1ZR (Karnataka).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1.2 Lakh. It is led by directors Jerry Kuruvilla and Sherry Kuruvila.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.351 4th Main 9th Cross 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.88 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net loss of ₹64.21 Lakh (net margin -34.2%) and EBITDA of -₹14.79 Lakh (EBITDA margin -7.9%). Revenue has grown at a compounded annual rate (CAGR) of 212% over three years and 360% over five years.
As per MCA filings, the company has open charges of ₹70 Lakh on record.
Cemil Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0196223). For more details, the company can be reached via its website cemilbio.com.
Company details
CIN U24100KA2019PTC120414
Registration Number 120414
Incorporation Date 15 January 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0196223
Key People
Jerry Kuruvilla Director Sherry Kuruvila Director Recognitions & Rankings of Cemil Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0196223
Contact details
Cemil Biosciences Private Limited's registered office is in Bangalore, Karnataka. Its website is cemilbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.351 4th Main 9th Cross 4th Phase Peenya Industrial Area, Bangalore, Karnataka, India – 560058
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Cemil Biosciences Private Limited, buy the company report.
Comprehensive company report
Cemil Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cemil Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cemil Biosciences Private Limited, buy the company report.
Financials of Cemil Biosciences Private Limited
FY 2025 filings availableCemil Biosciences Private Limited reported revenue of ₹1.88 Cr (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹1.88 Cr ▲ 28%
Net loss · FY 2025
₹64.21 Lakh margin -34.2%
EBITDA · FY 2025
-₹14.79 Lakh margin -7.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 212%
5 years · compounded
▲ 360%
EBITDA CAGR growth
1 year
▼ 148%
3 years · compounded
▼ 118%
5 years · compounded
▼ 11%
Revenue has grown at a compounded annual rate (CAGR) of 360% over five years, including 28% growth in the latest year. EBITDA fell 148% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹14.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹64.21 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.9% | ||||
| Net Profit Margin | -34.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cemil Biosciences Private Limited, buy the company report.
Board of directors of Cemil Biosciences Private Limited
Cemil Biosciences has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jerry Kuruvilla | Director | 15 Jan 2019 | 7 Years 9 Months | Current |
| Sherry Kuruvila | Director | 15 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Cemil Biosciences Private Limited is audited by K S SATHYANARAYANA AND CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S SATHYANARAYANA AND CO | FY 2021 | 008999S |
Shareholding
The shareholding of Cemil Biosciences Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cemil Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹70 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Aug 2024 | 100972047 | Sidbi | ₹70 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cemil Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cemil Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cemil Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCC9649M1ZR | Karnataka | Active | 16 Apr 2019 |
To see the full GST registrations and return filing status of Cemil Biosciences Private Limited, buy the company report.
Recent activity
Cemil Biosciences Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Jerry Kuruvilla was appointed as Director on 15 Jan 2019.
AGM
Cemil Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cemil Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Sidbi amounted to Rs. 0.70 Cr with Charge ID 100972047 was registered on 23 Aug 2024.
Appointed
Jerry Kuruvilla was appointed as Director.
Appointed
Sherry Kuruvila was appointed as Director.
Incorporation
15 Jan 2019
Cemil Biosciences Private Limited was registered on 15 Jan 2019 with Roc Bangalore & aged 7 years 9 months as per MCA records.
Frequently asked questions
Cemil Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 15 January 2019 (7+ years old) and is registered under CIN U24100KA2019PTC120414.
Cemil Biosciences has 2 current directors:
- Jerry Kuruvilla - Director
- Sherry Kuruvila - Director
The latest financial statements of Cemil Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Cemil Biosciences is 29AAHCC9649M1ZR, registered in Karnataka.
The CIN (Corporate Identification Number) of Cemil Biosciences is U24100KA2019PTC120414. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cemil Biosciences was incorporated on 15 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Jerry Kuruvilla was appointed as Director on 15 Jan 2019. Sherry Kuruvila was appointed as Director on 15 Jan 2019.
Yes, Cemil Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Cemil Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0196223).
Cemil Biosciences can be reached through the website cemilbio.com. Its registered office is in Bangalore, Karnataka, India.